May BNF/BNFC Newsletter

Monograph on CMV immunoglobulin has been added to BNF/BNFC and 4 monographs to BNF (romosozumab, polatuzumab vedotin, mogamulizumab, ravulizumab), as well as MHRA advice on baricitinib, benzodiazepines, SGLT2 inhibitors, opioids, tofacitinib, ulipristal acetate and upadacitinib.

British National Formulary